Interact Direct Holdings Limited Files Late Early Warning Report 
Universal Digital Acquires 10 Bitcoin in First Treasury Allocation 
Gorilla Provides Business Updates 
ISS Recommends Sonim Technologies Stockholders to Vote “FOR” Company Nominees on the WHITE Proxy Card IPSEN – Buy-back programme – Art 5 of MAR – Week 25 – 2023
Aggregated presentation by day and by market Name of issuer Identification code of issuer (Legal…
AIM ImmunoTech Announces Publication of Positive Findings from a Pre-Clinical Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the American Journal of Cancer Research
Findings support efforts in ongoing Early Access Program and upcoming clinical trials, and suggest Ampligen’s…
Trethera Receives Grant from National Institute of Allergy and Infectious Diseases for the Advancement of TRE-515 in Lupus
Figure 1 PET scan images showing presence of target enzyme dCK in normal mice (row…
Verizon Business elevates fixed-wireless offering with new management portal and security solutions
What you need to know: Verizon Business Internet Portal allows customers to view and manage…
Strategic Biofuels Selects SLB for Carbon Sequestration Services on Carbon-Negative Fuels Project in Louisiana
SLB will support the CO2 sequestration efforts for the Louisiana Green Fuels Project, capable of…
Bluesky Releases Bluesky ‘Copilot for Snowflake’ at Snowflake Summit 2023
Bluesky’s ‘Copilot for Snowflake’ helps companies get more value out of their Snowflake Data Cloud…
RisingWave Cloud Democratizes Event Stream Processing, Making It Affordable at Cloud Scale
Innovative distributed SQL processing enables continuous intelligence and faster, more precise business decisions SAN FRANCISCO,…
Intetics CEO Boris Kontsevoi Highlights the Success Potential of Conversational AI in Business
NAPLES, Fla., June 27, 2023 (GLOBE NEWSWIRE) — Boris Kontsevoi is a technology executive, President…
Datametrex Cancels Investor Relations Agreement and Grant of Options
Toronto, Ontario–(Newsfile Corp. – June 27, 2023) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB:…
All Comcast NBCUniversal LIFT Labs Generative AI Accelerator Participants Secure Partnerships with Comcast, NBCUniversal, or Sky
Six-week immersive program featuring eight founders concludes with a Generative AI Summit PHILADELPHIA–(BUSINESS WIRE)–Today, Comcast…
Trinity Hunt Partners Acquires Digital Marketing Company REQ
Washington, DC-based REQ will support THP’s vision to rapidly scale through strategic investments to create…
Esker To Pay €0.75 per Share As Dividend for 2022, Up 25%, Affirming Growth Momentum for 2023
Long-standing shareholders to receive a 10% bonus LYON, France & MIDDLETON, Wis.–(BUSINESS WIRE)–Esker, a global…
KBRA Releases Research – CMBS Loan Performance Trends: June 2023
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a report on U.S. commercial mortgage-backed securities (CMBS) loan performance trends…
LifeArc strengthens Board of Trustees with new appointments
LifeArc strengthens Board of Trustees with new appointments 27 June 2023: LifeArc, the self-funded medical…
LifeArc strengthens Board of Trustees with new appointments
LifeArc strengthens Board of Trustees with new appointments 27 June 2023: LifeArc, the self-funded medical…
GRI Bio (NASDAQ: GRI) Bolsters Patent Portfolio
– U.S. patent issuance for lead program, GRI-0621, in development for the treatment of idiopathic…
GRI Bio (NASDAQ: GRI) Bolsters Patent Portfolio
– U.S. patent issuance for lead program, GRI-0621, in development for the treatment of idiopathic…
AIM ImmunoTech Announces Authorizations from Competent Authority and Ethics Board in the Netherlands to Begin a Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi (durvalumab) for the Treatment of Pancreatic Cancer
Ampligen has shown therapeutic synergies with checkpoint inhibitors, potentially increasing survival rates and efficacy Patient…
AIM ImmunoTech Announces Authorizations from Competent Authority and Ethics Board in the Netherlands to Begin a Phase 1b/2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi (durvalumab) for the Treatment of Pancreatic Cancer
Ampligen has shown therapeutic synergies with checkpoint inhibitors, potentially increasing survival rates and efficacy Patient…
Bavarian Nordic Reports Phase 3 Topline Results for its COVID-19 Booster Vaccine Candidate
Booster study successfully met its primary objective, demonstrating non-inferiority to mRNA-vaccine Regulatory pathway will depend…